Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PathoGenesis signs European distribution agreements and launches TOBI in two new markets

June 1, 1999

Improved PDE4 inhibitors in development at Merck Frosst

May 26, 1999

Muscarinic antagonists from Tokyo Tanabe particularly useful for respiratory disorders

May 25, 1999

Yoshitomi reports potent and selective tryptase inhibitors with oral activity

May 24, 1999

Ipratropium bromide may improve sleep, nocturnal oxygen in COPD patients

May 24, 1999

Different crystalline forms of cipamfylline studied at SB

May 21, 1999

Merck discloses potent, selective and orally active PDE4 inhibitors

May 21, 1999

Positive findings from phase III trial of anti-IgE for allergic rhinitis

May 19, 1999

Inflazyme signs collaborative agreement with HMR for asthma and allergy therapeutics

May 19, 1999

Johnson & Johnson withdraws from norastemizole collaboration

May 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...